| $350M | ||
| $241M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings are EsoCheck, an esophageal cell collection device vital for the early detection of esophageal adenocarcinoma and Barrett's Esophagus (BE), and EsoGuard, a specialized bisulfite-converted next-generation sequencing DNA assay. The company's extensive development pipeline further encompasses EsoCure, an esophageal ablation device intended to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; and NextFlo, a disposable infusion platform technology. Also in development are the Veris cancer healthcare platform, which features an intelligent vascular port for combined remote monitoring and data analytics, alongside Veris cardiac monitors. Additional innovations include NextVent single-use ventilators, FlexMO medical circulatory support cannulas, DisappEAR resorbable pediatric ear tubes, and Solys for noninvasive glucose monitoring. Established in 2014, the enterprise originally traded as PAXmed Inc. before rebranding to PAVmed Inc. in April 2015. Its corporate headquarters are located in New York, New York.
Over the last 12 months, insiders at PAVmed Inc. have bought $0 and sold $0 worth of PAVmed Inc. stock.
On average, over the past 5 years, insiders at PAVmed Inc. have bought $161,009 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 100,000 shares for transaction amount of $62,320 was made by Glennon Michael J (director) on 2022‑12‑07.
| 2022-12-07 | Glennon Michael J | director | 100,000 0.1128% | $0.62 | $62,320 | -35.65% | ||
| 2022-12-06 | Glennon Michael J | director | 88,000 0.1032% | $0.64 | $56,082 | -34.43% | ||
| 2022-12-05 | Glennon Michael J | director | 62,000 0.0713% | $0.69 | $42,606 | -40.22% | ||
| 2021-03-18 | Aklog Lishan | Chairman and CEO | 7,500 0.0102% | $4.31 | $32,324 | +16.12% | ||
| 2020-11-25 | Sale | SIROVICH MATTHEW | 10 percent owner | 33,203 0.0686% | $1.96 | $65,048 | +158.16% | |
| 2020-11-24 | Sale | SIROVICH MATTHEW | 10 percent owner | 53,036 0.11% | $2.00 | $105,876 | +154.27% | |
| 2020-11-19 | Sale | SIROVICH MATTHEW | 10 percent owner | 75,211 0.1596% | $1.83 | $137,418 | +184.27% | |
| 2020-11-18 | Sale | SIROVICH MATTHEW | 10 percent owner | 24,789 0.0502% | $1.78 | $44,164 | +178.02% | |
| 2020-05-29 | Sale | SIROVICH MATTHEW | 10 percent owner | 131,082 0.2912% | $1.98 | $259,477 | +5.03% | |
| 2020-05-28 | Sale | SIROVICH MATTHEW | 10 percent owner | 69,839 0.162% | $2.06 | $143,666 | +5.56% | |
| 2019-05-24 | MCGRATH DENNIS M | President & CFO | 5,000 0.0184% | $1.09 | $5,429 | +1.87% | ||
| 2019-05-23 | Aklog Lishan | Chairman and CEO | 30,000 0.1072% | $1.09 | $32,850 | -1.80% | ||
| 2018-08-28 | Aklog Lishan | Chairman and CEO | 30,000 0.1084% | $1.18 | $35,400 | -12.20% | ||
| 2018-06-08 | Sale | Greenspan Ira Scott | 10 percent owner | 18,300 0.0967% | $1.04 | $19,032 | +10.49% | |
| 2018-06-01 | Sale | Greenspan Ira Scott | 10 percent owner | 532,255 2.6899% | $0.97 | $516,287 | +12.76% | |
| 2017-11-20 | Aklog Lishan | Chairman and CEO | 950 0.0075% | $4.70 | $4,465 | -66.22% | ||
| 2017-11-17 | Aklog Lishan | Chairman and CEO | 601 0.0045% | $4.37 | $2,626 | -65.13% | ||
| 2017-09-15 | Aklog Lishan | Chairman and CEO | 2,600 0.0238% | $8.77 | $22,814 | -76.88% | ||
| 2017-09-13 | Aklog Lishan | Chairman and CEO | 300 0.0022% | $6.88 | $2,065 | -76.78% | ||
| 2017-09-12 | Aklog Lishan | Chairman and CEO | 100 0.0007% | $6.66 | $666 | -76.29% |
| Aklog Lishan | Chairman and CEO | 1105913 13.831% | $1.74M | 48 | 0 | +16.12% |
| SIROVICH MATTHEW | 10 percent owner | 1027744 12.8534% | $1.61M | 0 | 6 | |
| MCGRATH DENNIS M | President & CFO | 529000 6.6159% | $830,900.30 | 5 | 0 | |
| Greenspan Ira Scott | 10 percent owner | 421691 5.2738% | $662,350.05 | 0 | 2 | |
| Glennon Michael J | director | 250000 3.1266% | $392,675.00 | 3 | 0 | |
| Fitzgerald Richard F | CFO and Secretary | 200 0.0025% | $314.14 | 2 | 0 | |
| Lamstein Joshua R | director | 100 0.0013% | $157.07 | 1 | 0 |
| Increased Positions | 16 | +51.61% | 211,461 | +401.87% |
| Decreased Positions | 10 | -32.26% | 8,607 | -16.36% |
| New Positions | 6 | New | 131,287 | New |
| Sold Out Positions | 6 | Sold Out | 8,529 | Sold Out |
| Total Postitions | 37 | +19.35% | 255,473 | +385.51% |
| First Manhattan Co. Llc. | $174.00 | 2.38% | 23,801 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $51.00 | 0.7% | 6,945 | +4,229 | +155.71% | 2025-09-30 |
| Jane Street Group, Llc | $37.00 | 0.51% | 5,076 | +3,320 | +189.07% | 2025-09-30 |
| Geode Capital Management, Llc | $24.00 | 0.32% | 3,219 | +263 | +8.9% | 2025-09-30 |
| Blackrock, Inc. | $18.00 | 0.24% | 2,422 | 0 | 0% | 2025-09-30 |
| Captrust Financial Advisors | $16.00 | 0.22% | 2,168 | 0 | 0% | 2025-09-30 |
| Lpl Financial Llc | $14.00 | 0.19% | 1,851 | 0 | 0% | 2025-09-30 |
| Northern Trust Corp | $11.00 | 0.16% | 1,549 | +1,159 | +297.18% | 2025-09-30 |
| Virtu Financial Llc | $10.00 | 0.13% | 1,299 | +1,299 | New | 2025-09-30 |
| Obermeyer Wealth Partners | $5.00 | 0.07% | 717 | 0 | 0% | 2025-09-30 |